← FDA Drug Approvals (Drugs@FDA)

RANLUSPEC

BLA · Biologics License Application · Sponsor: LUPIN LIMITED · Approved 2026-06-02

Drug application

FDA Application #

BLA761480

Application type

Biologics License Application

Brand name

RANLUSPEC

Generic name

Ranibizumab-Hkdz

Active ingredients

RANIBIZUMAB-HKDZ

Dosage form

INJECTION

Route

—

Marketing status

Prescription

Sponsor

LUPIN LIMITED

First approval

2026-06-02

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown